ASND
Ascendis Pharma AS
228.00$
+0.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures per share in EUR.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.06 | 0.58 | -1.09 | -1.83 | -2.27 | -2.83 | -3.38 | -3.78 | -5.36 | -7.63 | -8.84 | -8.30 | -5.29 | 0.85 | |
| 0.04 | 0.04 | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 | 0.14 | 0.19 | 0.28 | 0.32 | 0.34 | 0.31 | 0.28 | |
| 0.01 | 0.06 | 0.08 | 0.07 | 0.28 | 0.29 | 0.48 | 0.81 | 1.05 | 1.22 | 1.14 | 1.18 | 1.65 | 1.92 | |
| – | 0.12 | -0.13 | -0.35 | 0.13 | 0.69 | -0.27 | 0.67 | 2.74 | -0.01 | 1.57 | – | – | – | |
| -0.23 | 0.05 | -0.44 | -0.20 | 0.15 | 0.15 | 0.04 | 0.09 | -0.02 | -0.89 | -0.22 | -1.77 | -1.85 | 1.12 | |
| 0.03 | 0.11 | 0.02 | 0.04 | 0.03 | 0.03 | 0.06 | 0.11 | 0.43 | 0.44 | 0.26 | 0.04 | 0.02 | 0.13 | |
| -0.03 | -0.11 | -0.02 | -0.04 | -0.03 | -0.03 | -0.06 | -0.11 | -5.75 | -2.02 | 1.10 | 5.09 | 0.12 | -0.13 | |
| – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.61 | 0.09 | – | – | – | |
| – | 10.57 | 8.15 | 4.80 | 4.74 | 3.96 | 5.27 | 11.38 | 0.00 | -0.39 | -1.88 | -0.03 | 0.00 | -0.28 | |
| – | -0.02 | 0.00 | 0.00 | -0.15 | -0.12 | -0.10 | -0.09 | -0.09 | -0.12 | 8.86 | 2.24 | 2.12 | -0.36 | |
| -0.02 | -0.02 | 2.83 | 4.45 | 4.42 | 3.71 | 4.95 | 10.61 | 11.91 | 6.42 | 7.08 | 2.39 | 7.67 | 0.58 | |
| -0.11 | 0.45 | 1.81 | 2.92 | 2.28 | 0.45 | 2.01 | 6.89 | -0.27 | -2.52 | -0.03 | -0.93 | 2.89 | 2.02 | |
| -0.09 | 0.47 | -1.11 | -1.87 | -2.29 | -2.86 | -3.44 | -3.89 | -5.79 | -8.07 | -9.10 | -8.35 | -5.31 | 0.72 |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.